Letter From Attorney General Lungren to Lann Lee RE: CHDP Program Letter #91-18
Correspondence
October 24, 1991

6 pages
Cite this item
-
Case Files, Matthews v. Kizer Hardbacks. Letter From Attorney General Lungren to Lann Lee RE: CHDP Program Letter #91-18, 1991. 1d6c3a77-5c40-f011-b4cb-7c1e5267c7b6. LDF Archives, Thurgood Marshall Institute. https://ldfrecollection.org/archives/archives-search/archives-item/a398884c-2124-4283-b5bd-21f7bb070c73/letter-from-attorney-general-lungren-to-lann-lee-re-chdp-program-letter-91-18. Accessed October 08, 2025.
Copied!
- * DANIEL E. LUNGREN State of California Attorney General DEPARTMENT OF JUSTICE 2101 WEBSTER STREET, 12th FLOOR OAKLAND, CA 94612-3049 (510)464-4200 MAILING ADDRESS: 455 GOLDEN GATE AVENUE, SUITE 6200 SAN FRANCISCO, CA 94102-3658 (510) 464-1173 October 24, 1991 Bill Lann Lee NAACP Legal Defense and Educational Fund, Inc. 315 West Ninth Street, Suite 208 Los Angeles, California 90015 RE: Erika Matthews, et al. v. Molly Coye U.S.D.C. Northern District No. C-90-3620 EFL Dear Bill: Pursuant to our telephone conversation of October 23, 1991 (as well as plain common sense) I am forwarding a copy of CHDP Program Letter #91-18 which distributed Provider Information Notice #91-10. Both documents are dated October 21, 1991. As we discussed, please let us know who should be listed as payee on the warrant for attorneys fees. The Department of Health Services is moving expeditiously on this front too. All best regards to you and your colleagues. It is always a pleasure to deal with cooperative and competent professionals in creating a result beneficial to all concerned. Sincerely, DANIEL E. LUNGREN Attorney General oid / / rl 7 / ir rT (LR HARLAN E. VAN WYE Deputy Attorney General HEV:lej Enclosures cc: Linda Slaughter (w/out encl.) “a © oe STATE OF CALIFORNIA—HEALTH AND WELFARE AGENCY PETE WILSON, Governor DEPARTMENT OF HEALTH SERVICES 714/744 P STREET P.O. BOX 942732 SACRAMENTO, CA 94234-7320 (916) 654-0364 October 21, 1991 CHDP Program Letter #91-18 To: Community Child Health and Disability Prevention (CHDP) Program Directors and Deputy Directors Subject: Provider Information Notice #91-10 Regarding Blood Lead Test as a Part of Health Assessment for CHDP Eligible Children Ages 6 Months to 72 Months Attached is Provider Information Notice #91-10 informing providers of the need 71 assess all children from 6 months to 72 months of age for risk of lead burden and do a blood lead test when determined to be at risk. do blood lead testing on all children at one year of age. do blood lead testing on any child under 72 months of age who has not been tested. : Distributing this notice is a condition of settling the law suit Mathews and People United for a Better Oakland v. Coye and must be distributed without any changes no later than October 30, 1991 to all your providers. Return the “Notice of Distribution" by November 1, 1991 and include the date sent to providers. If you have any questi , e contact your Regional u (omy don H. br 1 Ph.D. cree] Child Health and Disability Prevention Branch Consultant. STATE OF CALIFORNIA—HEALTH AND WELFARE AGENCY PETE WILSON. Governor DEPARTMENT OF HEALTH SERVICES 714/744 P STREET P.O. BOX 942732 SACRAMENTO, CA 94234-7320 (916) 657-1425 Jer Gtee 1, 1H CHDP Provider Information Notice #91-10 To: CHDP Providers Subject: Blood Lead Test as a Part of Health Assessment for CHDP Eligible Children Ages 6 Months to 72 Months In March of 1991, you received a letter from the Director of the Department of Health Services which, in part, stated: "Lead poisoning is the most significant environmental health problem facing California children today, and insufficient consideration is being given this potential problem during routine child health evaluations." The Department is acting on this concern by expanding the blood lead testing/screening component of the health assessment provided to Child Health and Disability Prevention (CHDP) Program eligible children. Effective November 20, all CHDP eligible children between 6 and 72 months are to receive an evaluation for possible lead poisoning as part of each health ‘assessment. The evaluation shall include, at a minimum: 1. A blood lead test (Code #15) is to be administered to all CHDP program eligible children at approximately one year of age, unless there is reason that the test is medically contraindicated or the test is refused by the parents. 2. Any child over one year of age, but less than 73 months, who has noc been tested for. lead. poisoning is to also receive a blood lead test (Code #15) during the child’s next subsequent periodic health assessment unless there is reason that the test is medically contraindicated or the test is refused by the parents. 3. A series of five (5) questions, intended to identify children at high risk for lead poisoning, is to be directed to each child's parent/guardian. The questions (See attached list) are to be asked ac each periodic health assessment, beginning with the 6 month visit. A child is considered low risk only if all five questions are answered "No." If any child is determined to be high risk from initial or subsequent questioning, a blood lead test (Code #15) is to be administered immediately unless there is reason that the test is medically contraindicated or the test is refused by che parents. 4 AC each subsequent periodic health assessment, Lf a child is determined vs be high risk under paragraphs 1, 2, or 3 apove, a1 blood test (Coda #15) is to be performed, unless thera is reason chat the rest is medically contraindicated or rhe test is refused by the parcncs. s A child is to be referred for appropriate diagnosis and/or treatment when the results of tha blood leval test exceed 13 ug/dL. A child whose blood lead test results are greater chan 10 ug/dL and less than 13 ug/dL ig to be retasted at intervals consistent with the Qetober 1991 Canters for Dissase Control statement enticled, Pravencing Lead Poisoning In Young Children. The reimbursement rates for the healch assessment and the blood lead test are unchanged. These changas {in the cesting/scrcening seococol are being made because of reecant medical and scientific advancas. The concent of =his provider information letter 1s intended to be consistent with these changes. The Cancers for Disease Control scatement recommends a second universal test ac about two vears of age if resources allow. The Department will keep you informed of further davelopments and more derailad inscructions will follow, Please feel free TO call your lecal CHDP program director if you nave any questicns. fLR..2 Molly Joel Cove, M.D. a2 A Director Attachment Sr ——— ———— TT A i — hs hl Sl tg gpp— TT Lv — ll fra" oo . re CHILDHOOD LEAD POISONING EVALUATION QUESTIONNAIRE The following questions are to be answered by the parents/guardians of CHDP eligible children under 72 months of age at each periodic health assessment. 1. Does your child live in or regularly visit a house or other location with peeling or chipping paint built before 1960? (This can include a day care center, preschool, scheccl, barn, home of babysitter, relative, friend, etc.) Yes No Does your child live in or regularly visit a house built before 1960 with recent or ongoing renovation or remodeling? Yes No Does your child have a parent, brother, sister, housemate or playmate who is being treated or followed for lead poisoning (i.e., blood lead > 10 ug/dL? a Yes No Does your child live with someone whose job or hobby involves exposure to lead (i.e., painting, soldering, automobile battery manufacturing or recycling, vehicle radiator repair)? : Yes No Does your child live near an active lead smelter or battery recycling plant or other industry likely to release lead? Yes No o @ REPORT OF DISTRIBUTION PROVIDER INFORMATION NOTICE #91-10 BLOOD LEAD TEST AS A PART OF HEALTH ASSESSMENT FOR CHDP ELIGIBLE CHILDREN AGES 6 MONTHS TO 72 MONTHS TO: PROVIDER INFORMATION CLERK CALIFORNIA STATE DEPARTMENT OF HEALTH SERVICES CHILD HEALTH AND DISABILITY PREVENTION BRANCH 714 P STREET, ROOM 708 P.O. BOX 942732 SACRAMENTO, CA 94234-7320 THIS PROVIDER INFORMATION NOTICE WAS SENT TO PROVIDERS IN COUNTY /COMMUNITY ON . (DATE) a, . SIGNATURE OF SENDER PLEASE NOTE THAT NO CHANGE IS TO BE MADE IN THIS NOTICE OR ATTACHMENTS. PLEASE COMPLETE THIS FORM AND FORWARD TO ADDRESS SHOWN ABOVE. THANK YOU FOR YOUR COOPERATION.